Paylocity Holding Corporation — Fiscal 2024 First Quarter Form 10-Q
Reporting period: Three months ended September 30, 2023, compared with the three months ended September 30, 2022. The filing is an unaudited interim report. Paylocity provides cloud-based human capital management and payroll software through a SaaS model.
Financial performance
| Metric | Q1 FY2024 | Q1 FY2023 | Change |
|---|---|---|---|
| Total revenue | $317.6 million | $253.3 million | 25% |
| Recurring and other revenue | $291.7 million | $245.4 million | 19% |
| Interest income on client funds | $25.9 million | $7.9 million | 229% |
| Gross profit | $216.1 million | $168.7 million | 28% |
| Operating income | $41.2 million | $7.1 million | 481% |
| Net income | $34.5 million | $30.4 million | 14% |
| Diluted earnings per share | $0.61 | $0.54 | 13% |
| Adjusted EBITDA | $104.9 million | $66.6 million | 57% |
Gross margin improved to 68% from 67%. Operating margin increased to 13% from 3%, while net margin was approximately 11% versus 12% in the prior-year quarter. The margin comparison was affected by the substantial increase in interest income and by the prior-year tax benefit.
Cash flow, balance sheet, debt and liquidity
- Cash flow from operating activities was $62.1 million, compared with $16.4 million in the prior-year quarter.
- Capitalized internal-use software costs were $14.2 million, and purchases of property and equipment were $3.5 million.
- Cash and cash equivalents totaled $305.0 million at September 30, 2023.
- Funds held for clients totaled $2.53 billion, supported by corresponding client fund obligations of $2.53 billion. These balances fluctuate with payroll and tax payment timing and are not generally available for corporate purposes.
- Available-for-sale securities held for clients had a fair value of $481.7 million and $5.8 million of gross unrealized losses. No credit impairment losses were recognized.
- The company had no borrowings under its $550.0 million revolving credit facility, which may be increased to $825.0 million subject to conditions. The facility matures in August 2027, and the company was in compliance with its covenants.
- Management stated that cash, operating cash flow and available credit are expected to satisfy working capital, capital expenditure and other liquidity needs for at least the next 12 months and the foreseeable future.
Material changes versus the prior comparable period
- Recurring and other revenue rose $46.3 million, primarily from new and existing client growth and sales execution.
- Interest income increased $18.0 million because of higher interest rates and higher average client-fund balances.
- Cost of revenues increased 20% to $101.5 million, driven mainly by additional personnel, delivery and processing costs, and software amortization.
- Sales and marketing expense increased 13% as the company expanded its sales organization. Research and development expense increased 11%, while general and administrative expense decreased 1%.
- Operating cash flow improved by $45.8 million. Net cash used in investing activities declined to $9.4 million from $89.5 million, primarily because of higher proceeds from securities sales and maturities and lower securities purchases.
- Net cash used in financing activities was $122.4 million, principally reflecting a $93.6 million decrease in client fund obligations and $28.8 million of taxes paid on net share settlements of equity awards.
- Stock-based compensation expense was $39.0 million, and $43.96 million was recorded as stock-based compensation in the statement of changes in equity. Unrecognized compensation cost for unvested awards totaled approximately $241.5 million.
Guidance, outlook, risks and unusual items
- No specific numerical revenue, earnings or margin guidance is provided in the filing text.
- Management expects continued investment in sales, marketing, research and development, personnel, infrastructure and client service. These investments may increase costs before producing benefits, although management expects long-term operating leverage and margin improvement.
- Results are subject to fluctuations in client employee counts, client losses, sales execution, interest rates, inflation, economic conditions and the timing of payroll and tax obligations. Fiscal third-quarter results are seasonally affected by W-2 preparation and higher client-fund balances.
- The effective tax rate was 22.3% in Q1 FY2024, compared with a benefit rate of 338.2% in the prior-year quarter. The prior-year benefit primarily reflected excess stock-compensation tax benefits and a valuation allowance decrease.
- The company faces two potential class actions alleging violations of the Illinois Biometric Information Privacy Act. The company cannot currently estimate a reasonably possible loss or range of loss and intends to defend the matters vigorously.
- A hypothetical immediate 100-basis-point change in interest rates would have changed the fair value of available-for-sale securities by approximately $5.9 million in either direction as of September 30, 2023. The company has not used derivatives to hedge this exposure.
- Commitments included $79.5 million of operating lease obligations and $53.4 million of purchase obligations, with $10.7 million and $31.8 million, respectively, due within 12 months.
- Management reported effective disclosure controls and no material changes in internal control over financial reporting.
Investor verification checklist
- Verify the sustainability of revenue growth excluding the $18.0 million year-over-year increase in interest income on client funds.
- Assess sensitivity of earnings and cash generation to interest rates, client-fund balances and securities valuations.
- Reconcile non-GAAP Adjusted EBITDA of $104.9 million to GAAP net income and review the substantial stock-based compensation expense.
- Monitor operating leverage, especially sales and marketing, research and development, capitalized software and deferred contract costs.
- Review the potential financial exposure and developments in the two Illinois biometric-information lawsuits.
- Confirm the timing and availability of client funds versus corporate cash, particularly because client fund assets are matched by client fund obligations.
- Review the filing’s liquidity disclosure: the notes report $481.7 million of available-for-sale securities, while the MD&A text states that no corporate investments were classified as available-for-sale securities; the filing text does not clearly explain this apparent inconsistency.